RBV Capital

Investor type

VC

Founded

2014

AUM

-

Location

Switzerland

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Series A, Seed, Series B

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 06 December, 2025

Profile

RBV Capital is a dedicated life sciences venture fund based in Moscow, Russia with partnership office in Wilen, Switzerland. We invest into diversified assets in pharmaceuticals, biologics, digital healthcare products and medical devices answering to an unmet medical and market need and with a potential for global outreach. Please, visit our web site at www.rbvcapital.com

Industry

Biotechnology Healthcare Services AI Medical Devices Pharmaceuticals MedTech Technology Life Sciences HealthTech

Region of investment

Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
bdjaDSTWoKwQXrqu bdjaDSTWoKwQXrqu
bdjaDSTWoKwQXrqu
avatar
bdjaDSTWoKwQXrqu bdjaDSTWoKwQXrqu
bdjaDSTWoKwQXrqu
avatar
bdjaDSTWoKwQXrqu bdjaDSTWoKwQXrqu
bdjaDSTWoKwQXrqu
avatar
bdjaDSTWoKwQXrqu bdjaDSTWoKwQXrqu
bdjaDSTWoKwQXrqu
avatar
bdjaDSTWoKwQXrqu bdjaDSTWoKwQXrqu
bdjaDSTWoKwQXrqu
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about RBV Capital

RBV Capital is located in Switzerland.
RBV Capital was founded in 2014.
RBV Capital invests in companies and startups in Biotechnology, Healthcare Services, AI, Medical Devices, Pharmaceuticals, MedTech, Technology, Life Sciences, HealthTech.
RBV Capital invests in companies and startups in Europe.
RBV Capital invests in companies and startups at Series A, Seed, Series B.
RBV Capital usually invests $1-5 m on average.